Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 3, 2024
To
exert
their
beneficial
effects,
microorganisms
used
in
live
bacteria-containing
products
must
be
viable
and
present
certain
amounts.
In
this
study,
we
developed
a
viability
assay
based
on
quantitative
PCR
coupled
with
propidium
monoazide
for
the
identification
enumeration
of
Lactobacillus
acidophilus
Bifidobacterium
bifidum
.
order
to
optimize
protocol,
thermal
inactivation
conditions
two
target
PMA
concentration
inhibiting
DNA
amplification
from
dead
cells
while
allowing
it
were
first
determined.
The
viability-PCR
protocol
was
then
applied
analyze
commercial
product
containing
microorganisms.
quantities
both
determined
using
tested
significantly
higher
than
those
obtained
standard
plate
count,
suggesting
presence
bacteria
but
non-culturable
physiological
state.
Moreover,
lower
amounts
detected
compared
achieved
PCR,
possibly
because
samples.
Our
results
suggest
that
method
proposed
here
is
suitable
alternative
rapid
accurate
quantification
assessment
L.
B.
could
easily
adopted
quality
control
screening
products.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(11), P. 5842 - 5842
Published: May 27, 2024
This
study
provides
a
brief
discussion
of
the
major
nanopharmaceuticals
formulations
as
well
impact
nanotechnology
on
future
pharmaceuticals.
Effective
and
eco-friendly
strategies
biofabrication
are
also
highlighted.
Modern
approaches
to
designing
pharmaceutical
nanoformulations
(e.g.,
3D
printing,
Phyto-Nanotechnology,
Biomimetics/Bioinspiration,
etc.)
outlined.
paper
discusses
need
use
natural
resources
for
“green”
design
new
with
therapeutic
efficiency.
Nanopharmaceuticals
research
is
still
in
its
early
stages,
preparation
nanomaterials
must
be
carefully
considered.
Therefore,
safety
long-term
effects
not
overlooked.
The
testing
represents
an
essential
point
their
further
applications.
Vegetal
scaffolds
obtained
by
decellularizing
plant
leaves
represent
valuable,
bioinspired
model
nanopharmaceutical
that
avoids
using
animals.
Nanoformulations
critical
various
fields,
especially
pharmacy,
medicine,
agriculture,
material
science,
due
unique
properties
advantages
over
conventional
allows
improved
solubility,
bioavailability,
targeted
drug
delivery,
controlled
release,
reduced
toxicity.
have
transitioned
from
experimental
stages
being
vital
component
clinical
practice,
significantly
improving
outcomes
medical
fields
cancer
treatment,
infectious
diseases,
neurological
disorders,
personalized
advanced
diagnostics.
Here
key
points
highlighting
importance.
significant
challenges,
opportunities,
directions
mentioned
final
section.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(1), P. 194 - 194
Published: Jan. 18, 2024
Probiotics
are
known
to
promote
human
health
either
precautionary
in
healthy
individuals
or
therapeutically
patients
suffering
from
certain
ailments.
Although
this
knowledge
was
empirical
past
tomes,
modern
science
has
already
verified
it
and
expanded
new
limits.
These
microorganisms
can
be
found
nature
various
foods
such
as
dairy
products
supplements
formulated
for
clinical
preventive
use.
The
current
review
examines
the
different
mechanisms
of
action
probiotic
strains
how
they
interact
with
organism
host.
Emphasis
is
put
on
therapeutic
use
these
beneficial
conditions
gastrointestinal
tract.
Diseases
tract
particularly
any
malfunction
inflammation
intestines
seriously
compromise
whole
organism.
interaction
between
host’s
microbiota
alleviate
signs
symptoms
while
some
cases,
due
course,
intervene
underlying
pathology.
Various
safety
issues
probiotics
also
discussed.
AJP Endocrinology and Metabolism,
Journal Year:
2024,
Volume and Issue:
327(1), P. E89 - E102
Published: May 29, 2024
The
gut
microbiome,
a
complex
assembly
of
microorganisms,
significantly
impacts
human
health
by
influencing
nutrient
absorption,
the
immune
system,
and
disease
response.
These
microorganisms
form
dynamic
ecosystem
that
is
critical
to
maintaining
overall
well-being.
Prebiotics
probiotics
are
pivotal
in
regulating
microbiota
composition.
nourish
beneficial
bacteria
promote
their
growth,
whereas
help
maintain
balance
within
microbiome.
This
intricate
extends
several
aspects
health,
including
integrity
barrier,
responses,
producing
metabolites
crucial
for
metabolic
health.
Dysbiosis,
or
an
imbalance
microbiota,
has
been
linked
disorders
such
as
type
2
diabetes,
obesity,
cardiovascular
disease.
Impaired
barrier
function,
endotoxemia,
low-grade
inflammation
associated
with
toll-like
receptors
proinflammatory
pathways.
Short-chain
fatty
acids
derived
from
microbial
fermentation
modulate
anti-inflammatory
system
positively
influence
probiotics,
especially
Lactobacillus
Bifidobacterium
strains,
may
improve
outcomes,
glycemic
control
diabetes.
It
important
consider
strain-specific
effects
study
variability
when
interpreting
these
findings,
highlighting
need
further
research
optimize
therapeutic
potential.
aim
this
report
therefore
review
role
prebiotics
on
microbiome
role,
integrating
broad
understanding
physiological
mechanisms
clinical
perspective.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 972 - 972
Published: March 10, 2025
This
paper
makes
a
critical
evaluation
of
several
the
research
methods
used
to
investigate
relationship
between
diet,
health,
and
disease.
The
two
widely
are
randomized
controlled
trials
(RCTs)
prospective
cohort
studies.
RCTs
viewed
as
being
more
reliable
than
studies
for
that
reason
placed
higher
in
hierarchy.
However,
have
inherent
flaws
and,
consequently,
they
may
generate
findings
less
those
from
text
presents
discussion
errors
occur
result
confounding.
refers
correlation
exposure
outcome
with
other
variables
can
mask
true
association
or
produce
false
associations.
Another
source
error
is
reverse
causation,
which
most
commonly
associated
cross-sectional
These
do
not
allow
researchers
determine
temporal
sequence
lifestyle
inputs
together
health-related
outcomes.
As
result,
it
be
unclear
cause
effect.
also
illustrated
by
inverse
alcohol
intake
coronary
heart
Mechanistic
investigation
intricate
details
body
functioning
health
disease
this
strategy
biomedical
science.
evidence
presented
here
case
our
information
practical
value
field
nutrition
has
come
epidemiological
research,
including
RCTs,
whereas
mechanistic
been
minor
value.
Future Microbiology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: April 14, 2025
In
recent
years,
the
study
of
probiotics
has
advanced
significantly,
driven
by
growing
interest
in
their
potential
health
benefits
and
applications
food
pharmaceutical
industries.
Probiotics
are
claimed
to
enhance
gut
health,
modulate
immune
responses,
improve
digestion,
synthesize
beneficial
compounds
for
host,
even
impact
mental
through
gut-brain
axis.
However,
traditional
vitro
methods
identifying
have
limitations,
such
as
low
reproducibility
phenotypic
screening,
limited
capacity
discover
new
strains,
restricted
evaluation
safety,
inefficiencies
fully
understanding
biological
properties
responsible
health-promoting
effects.
Advancements
genomic
analysis
technology
provided
a
cost-effective
approach
further
explore
probiotic
strains
molecular
mechanisms
driving
effects
hosts.
Here,
we
describe
comprehensive
workflow
probiogenomic
aimed
at
establishing
gold-standard
pipeline
screening
based
on
genome
sequencing.
This
encompasses
steps
from
acquiring
genomes
safety-related
features,
plasticity,
markers
whole-genome
addition,
this
outlines
respective
methodological
approaches
provides
most
database
documented
date,
comprising
243
genes
potentially
associated
with
function.
PeerJ,
Journal Year:
2024,
Volume and Issue:
12, P. e17583 - e17583
Published: June 26, 2024
Background
Recent
studies
suggest
that
gut
microbiota
composition,
abundance
and
diversity
can
influence
many
chronic
diseases
such
as
type
2
diabetes.
Modulating
through
targeted
nutrition
provide
beneficial
effects
leading
to
the
concept
of
personalized
for
health
improvement.
In
this
prospective
clinical
trial,
we
evaluated
impact
a
microbiome-based
diet
on
hyperglycaemic
hyperlipidaemic
individuals.
Specifically,
BugSpeaks
®
-a
microbiome
profile
test
profiles
using
next
generation
sequencing
provides
nutritional
recommendation
based
individual
was
evaluated.
Methods
A
total
30
participants
with
diabetes
hyperlipidaemia
were
recruited
study.
The
15
(test
arm)
whole
genome
shotgun
metagenomics
recommendations
their
provided.
remaining
(control
provided
diabetic
guidance
3
months.
Clinical
anthropometric
parameters
HbA1c,
systolic/diastolic
pressure,
c-reactive
protein
levels
composition
measured
compared
during
Results
arm
(microbiome-based
nutrition)
showed
statistically
significant
decrease
in
HbA1c
level
from
8.30
(95%
confidence
interval
(CI),
[7.74–8.85])
6.67
CI
[6.2–7.05]),
p
<
0.001
after
90
days.
also
5%
decline
systolic
pressure
whereas
control
7%
increase.
Incidentally,
sub-cohort
patients
>130
mm
Hg
by
14%.
Interestingly,
CRP
found
drop
19.5%.
Alpha
measures
increase
Shannon
measure
(
0.05),
dietary
intervention.
intervention
led
minimum
two-fold
(Log2
fold
change
species
like
Phascolarctobacterium
succinatutens,
Bifidobacterium
angulatum,
Levilactobacillus
brevis
which
might
have
role
current
context
similar
Alistipes
finegoldii,
Sutterella
faecalis
been
earlier
shown
some
negative
host.
Overall,
study
indicated
net
positive
regime
correlated
parameters.
International Journal of Research in Dermatology,
Journal Year:
2025,
Volume and Issue:
11(2), P. 190 - 198
Published: Feb. 24, 2025
The
skin
microbiome,
comprising
diverse
microbial
communities,
is
pivotal
in
maintaining
cutaneous
homeostasis
and
modulating
immune
responses
immunodermatological
diseases.
This
review
provides
an
overview
of
recent
research
investigating
the
interplay
between
microbiome
autoimmune,
allergic,
inflammatory
conditions,
such
as
psoriasis,
eczema,
acne
vulgaris.
Current
evidence
suggests
that
alterations
composition,
termed
dysbiosis,
may
contribute
to
disease
pathogenesis
exacerbate
inflammation
disorders.
Furthermore,
microbial-derived
metabolites
immune-modulating
factors
produced
by
commensal
bacteria
can
influence
local
barrier
function.
Future
directions
include
evaluating
how
interacts
with
host
system,
identifying
biomarkers
for
diagnosis
prognosis,
exploring
microbiome-targeted
therapeutic
interventions,
probiotics,
transplantation,
metabolite
supplementation.
By
leveraging
insights
from
research,
personalized
approaches
managing
diseases
offer
novel
avenues
restoring
improving
patient
outcomes.
Biology,
Journal Year:
2024,
Volume and Issue:
13(3), P. 158 - 158
Published: Feb. 28, 2024
Background:
Probiotics,
as
supplements
or
food
ingredients,
are
considered
to
exert
promising
healthy
effects
when
administered
in
adequate
quantity.
Probiotics’
related
with
the
prevention
of
many
diseases,
well
decreasing
symptom
severity.
Currently,
most
available
data
concerning
their
potential
health
associated
metabolic
disorders,
including
gestational
diabetes
mellitus.
There
is
also
clinical
evidence
supporting
that
they
may
beneficial
against
diverse
adverse
pregnancy
outcomes.
The
purpose
current
narrative
study
extensively
review
and
analyze
existing
studies
probable
positive
impacts
probiotics
supplementation
during
a
protective
agent
outcomes
beyond
Methods:
comprehensive
thorough
literature
search
was
conducted
precise
scientific
databases,
such
PubMed,
Scopus,
Web
Sciences,
utilizing
efficient,
representative,
appropriate
keywords.
Results:
last
few
years,
recent
research
has
been
several
lipid
metabolism
dysregulation,
hypertensive
preterm
birth,
excessive
weight
gain,
caesarean
risk
section,
vaginal
microbiota
impairment,
mental
disturbances,
others.
Conclusion:
up
present
day,
there
only
preliminary
not
conclusive
results
for
probiotics’
pregnancy,
it
remains
questionable
whether
could
be
used
supplementary
treatment
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 28, 2023
Abstract
Recent
studies
suggest
that
gut
microbiota
composition,
abundance
and
diversity
can
influence
many
chronic
diseases
such
as
type
2
diabetes.
Modulating
through
targeted
nutrition
provide
beneficial
effects
leading
to
the
concept
of
personalized
for
health
improvement.
In
this
prospective
clinical
trial,
we
evaluated
impact
a
microbiome-based
diet
on
hyperglycaemic
hyperlipidaemic
individuals.
Specifically,
BugSpeaks
®
-
microbiome
profile
test
profiles
using
next
generation
sequencing
provides
nutritional
recommendation
based
individual
was
evaluated.
The
arm
[microbiome-based
nutrition]
showed
statistically
significant
decrease
in
HbA1c
level
[from
8.30
±
1.12
6.67
0.89,
p<0.001]
after
90
days.
arm,
also
5%
decline
systolic
pressure
whereas
control
7%
increase.
Incidentally,
sub-cohort
patients
with
>130mm
Hg
by
14%.
Interestingly,
CRP
found
drop
19.5%.
Alpha
measures
increase
Shannon
measure
[p<0.05],
dietary
intervention.
intervention
led
minimum
2-fold
[Log2
fold
change]
species
like
Phascolarctobacterium
succinatutens,
Bifidobacterium
angulatum,
Levilactobacillus
brevis
,
similar
non-beneficial
Alistipes
finegoldii,
Sutterella
faecalis
.
Overall,
study
indicated
net
positive
regime
correlated
parameters.